Regulated intramembrane proteolysis of the TGFβ type I receptor conveys oncogenic signals

Area of Science:

• Molecular biology
• Cancer research
• Cell signaling

Background:

• Cancer cells secrete transforming growth factor beta (TGFβ), a cytokine that binds cell surface receptors (TβRII and TβRI).
• TGFβ signaling activates Smad transcription factors, promoting epithelial-to-mesenchymal transition and cell invasion.
• Non-canonical TGFβ signaling pathways are not fully understood, necessitating further investigation into their molecular mechanisms.

Purpose of the Study:

• To investigate the molecular mechanisms of non-canonical TGFβ signaling in cancer cells.
• To identify novel oncogenic pathways driven by TGFβ.
• To explore the potential similarities between TGFβ and Notch signaling pathways.

Main Methods:

• Analysis of TGFβ-induced proteolytic cleavage of TβRI in cancer cells.
• Investigation of the nuclear translocation of TβRI intracellular domain.
• Assessment of the role of TβRI nuclear translocation in regulating pro-invasive gene transcription.
• Comparative analysis with Notch signaling pathways.

Main Results:

• TGFβ promotes the proteolytic cleavage of TβRI in cancer cells.
• The intracellular domain of TβRI translocates to the nucleus.
• Nuclear TβRI acts as a co-regulator to transcribe pro-invasive genes.
• This oncogenic TGFβ pathway shares similarities with the Notch signaling pathway.

Conclusions:

• A novel oncogenic TGFβ signaling pathway involves TβRI cleavage and nuclear translocation.
• This pathway contributes to cancer cell invasion by regulating pro-invasive gene expression.
• The identified pathway represents a potential therapeutic target for cancer treatment.
• Findings provide insights into growth factor receptor signaling via nuclear translocation.